Alcon AG vs Core Scientific Inc — how do they compare? Alcon AG trades at $72.96 (market cap $36.44B), while Core Scientific Inc trades at $21.34 (market cap $6.35B). The key difference: Alcon AG is far larger — about 5.7× Core Scientific Inc's market cap, and Alcon AG pays a 0.48% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.
| ALC | CORZ | |
|---|---|---|
Market Cap | $36.44B | $6.35B |
Sector | Health | Technology |
52-Week High | $90.12 | $29.16 |
52-Week Low | $62.02 | $13.55 |
Enterprise Value | $40.28B | $8.88B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →